Acorda Therapeutics
A publicly traded biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€168m (Public information from Apr 2024)
Share price
$0.258 ACOR
Town of Orangetown New York (HQ)
Authorizing premium user...